Slow – Beautifaire

24 Dec

Most visitors gazing on the Gainsborough and Reynolds portraits in London’s National Gallery or Royal Academy are almost certainly listening to the comb strokes, the backdrops or the poses of the lushly attired 18th-century aristocrats, military heroes and society figures. Not Lisa Eldridge. As an alternative, the style and celebrity makeup artist is looking closely on the eyes, hair and complexion of the artists’ subjects, making notes concerning the shade and position of blush on a cheek; the arch and color of the brows; and skin tone of ladies and men alike. Eldridge’s interest within the history and social politics of makeup is well-known. She wrote a book in 2015 called “Face Paint: The Story of Makeup,” and is a number one collector...

0 Comments

5 Nov

Dries Van Noten on Cultivating a Slow Fashion Brand

by Beautifaire101

Beauty, Featured

Dries Van Noten is all about slow fashion. Speaking on the WWD Apparel & Retail CEO Summit, the Belgian designer said he likes to remind young designers that it took him 10 years after graduating in 1982 to stage his first fashion show. “And even then it was a men’s show, really small, after which the ladies’s show was even later. So take your time. That I believe for each young designer, it’s vital, because some people just begin to run after which the issues are there,” he said in a conversation with WWD West Coast executive editor Booth Moore. The 2023 recipient of WWD’s Designer of the 12 months award, Van Noten has quite the opposite cultivated a slow and regular approach...

0 Comments

16 Jun

This Drug Could Slow Down Ovary Aging and Delay

by Beautifaire101

Beauty, Featured

Rapamycin, a drug currently undergoing clinical studies at Columbia University, could delay ovary aging and, in turn, delay menopause, while also reducing future symptom severity. The Columbia clinical study marks the primary time the drug has been tested on humans, because it has previously been tested on animals at several clinics, which showed that it could extend lifespan and slow aging. The trial, led by Dr. Zev Williams, chief of the division of reproductive endocrinology and infertility at Columbia University Fertility Center, and Dr. Yousin Suh, director of the reproductive aging program at Columbia, is a randomized, double-blind, placebo-controlled study taking a look at the consequences of weekly low dose rapamycin on women ages 35 to 42 over the course of three...

0 Comments

3 May